4//SEC Filing
Templeman Blaine 4
Accession 0001140361-18-025010
CIK 0001435049other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:25 PM ET
Size
4.9 KB
Accession
0001140361-18-025010
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2018-05-17$8.15/sh−2,000$16,300→ 69,937 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2018.
- [F2]The shares sold were originally acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2018.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001653641
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 6:25 PM ET
- Size
- 4.9 KB